Lumen Bioscience Is A Clinical Stage Biotechnology Company Based In Seattlewashingtonthe Company Specializes In Developing Biologic Drugs Using Genetically Engineered Spirulinaa Type Of Algaethis Innovative Platform Allows For The Efficient Production Of Therapeutic Proteinsmaking The Process Faster And More Cost Effective Than Traditional Methods Lumen Holds 33 Issued Patents And Has 19 Pendingshowcasing Its Commitment To Advancing Its Patented Technologythe Company Is Vertically Integratedmanaging All Aspects Of Drug Development In Housewhich Contributes To Quicker Development Timelinestheir Product Pipeline Includes Lmn 201An Orally Delivered Biologic Designed To Prevent Cdifficile Infectionsalong With Treatments For Gastrointestinal Diseasesmetabolic Diseasesand Traveler S Diarrhea With $94 Million In Funding To Date And An Additional $36 Million Raised In 2022Lumen Is Well Positioned For Growththe Company Has Also Been Recognized For Its Innovative Approachwinning The Wilkes Center Climate Prize In 2023 For Its Use Of Spirulina In Drug Development
No conferences found for this company.
| Company Name | Lumen Bioscience Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
